It was also detailed in a report from "*" although hidden in a section on most interesting director purchases 2019. Apparently they also ran a review oct 13 2019. You've probably already heared of these but just in case.
https://unauthorised investment advice/health/dr-borehams-crucible-recce-pharmaceuticals-the-emerging-superbug-killer/
https://unauthorised investment advice/director-trades/the-most-noteworthy-directors-trades-of-2019/
It was also detailed in a report from "*" although...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $130.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8000 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 42822 | 4 |
View Market Depth
| Last trade - 07.38am 06/05/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
Day chart unavailable